Info & Opinion
March 25, 2019
With news about FDA, CTMS, PMG Research, Inclinix, EMA, Hemofarm, Parexel and the Korea Drug Development Fund
David Underwood of Quanticate says some firms are giving short shrift to the basics of clinical trials
With news about Roche, Quintiles, Allscripts, Janssen, SGS, Oracle, TriReme, OpenClinica and FDA
The World Health Organization (WHO) says it is improving access to online data about clinical trials. It launched a web portal leading to several leading national databases about clinical trials. WHO says a “significant proportion” of trial research is never published, meaning doctors can lack information about treatment options. WHO also frets about selective reporting of clinical trial findings. Initially, data from 50,000 clinical trials provided by three registries—from Britain, Australia/New Zealand and the United States—have been put on the WHO site.
ESRNexus is a new search engine that may be of interest to clinical trials professionals. The interface is beautiful, the performance speedy. In combining ease of use and collectively-edited content, the effort appears to be a bybrid of Google and Wikipedia. To quote the site itself: “The database is designed to facilitate and promote the reuse of data that has been manually extracted from reference materials such as journal articles during the conduct of systematic reviews.” The search engine was developed by TrialStat, which offers a digital tool for systematic reviews. The ESRNexus site is especially strong with material from the Cochrane Collaborative or Campbell Collaboration and other sources of curated medical data. But unlike PubMed, it doesn’t appear to offer a way to get the full text of peer-reviewed articles.
Here’s a plug for an IBC conference, the China 2007 R&D Summit. It will be held June 4–7, 2007, at the Grand Hyatt Hotel in Shanghai. The summit is a forum for researchers and executives who are thinking of exploring business collaboration opportunities in China’s fast-growing life sciences industry. This workshop will cover the state of the art of preclinical GLP practices in China, and how they compare from a technical and regulatory perspective to the U.S. and EU. There will be an optional pre-conference workshop on good laboratory practices (GLP) in China.
A recent study conducted by ChainLink Research, an RFID and supply chain research firm, revealed three main areas of clinical trials where industry was anticipating adoption of the use of the technology. Bill McBeath, chief research officer at ChainLink Research, stressed that RFID has the potential to prevent mistakes related to manual data entry. To know more, visit http://www.chainlinkresearch.com
Aventyn, a provider of healthcare connected information processing solutions, has announced its latest offering, CLIP v1.2. Built upon the successful launch of the CLIP Clinical Information Processing Platform, this solution has integrated RFID capability. That allows major hospitals and medical supply manufacturers to connect patients and related medical assets. CLIP v1.2 integrates with Microsoft’s BizTalk RFID technology.
Amgen is betting on India. The biotech is setting up an office in India with the aim of testing its drugs in the country and exploring opportunities for partnerships. “Amgen is currently forming local affiliate companies in Mumbai and Hong Kong that will have the capability to conduct clinical trials in India and East Asia. Amgen’s affiliate in Mumbai will support the company’s clinical trials to take place in India,” said Amgen’s associate director, Mary Klem.